Bio Impact Capital LLC Provention Bio, Inc. Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$6.7 - $24.21 $1.84 Million - $6.67 Million
275,326 Added 30.64%
1,173,809 $28.3 Million
Q4 2022

Feb 14, 2023
BUY
$4.52 - $10.57 $714,788 - $1.67 Million
158,139 Added 21.36%
898,483 $9.5 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.62 $507,327 - $831,248
147,909 Added 24.97%
740,344 $3.33 Million
Q2 2022

Aug 11, 2022
BUY
$3.65 - $7.3 $2.16 Million - $4.32 Million
592,435 New
592,435 $2.37 Million

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email